OOIR: Observatory of International Research

Papers

(The H4-Index of Metabolism-Clinical and Experimental is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	770
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	570
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	220
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	210
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis	179
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation	179
Brown adipose tissue-derived metabolites and their role in regulating metabolism	166
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	162
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	157
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	129
PCSK9 in metabolism and diseases	124
Editorial Board	123
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic	122
Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4	117
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men	115
Editorial Board	113
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST	112
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	107
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	107
The role of active vitamin D in preventing sarcopenia—Authors' reply	104
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	90
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	88
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	81
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	79
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	77

Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation	75
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes	73
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health	73
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	68
Editorial Board	67
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models	67
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus	66
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	63
Association between hypertension and severity of NAFLD among adults with obesity	61
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	61
Editorial Board	61
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor	61
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	60
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	60
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	59
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	58
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	58
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	57
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	57
Role of mitochondria in pathogenesis and therapy of renal fibrosis	56
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	56
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications	55
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	55
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	54
Editorial Board	53
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia	52
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis	52